Regeneron Pharmaceuticals Inc (REGN) — Technical state

As of 2026-10-05 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

In a correction — 15.5% off its high

15.5% below its 52-week high and under its 50-day — a textbook 10-to-20% correction.

The moving-average stack

vs 20-day-6.6%
vs 50-day-7.6%
vs 200-day-1.3%
52-week band15.5% off the high · +34.6% off the low
Streak1 consecutive down session
Stochastic%K 8.5 · %D 12.7 · down cross

Continue: the REGN chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-10-05

Quick answers

What is the current Closelooknet signal on REGN?

In a correction — 15.5% off its high — 15.5% below its 52-week high and under its 50-day — a textbook 10-to-20% correction. As of 2026-10-05; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is REGN above its 50-day and 200-day moving averages?

As of 2026-10-05, Regeneron Pharmaceuticals Inc trades -7.6% below its 50-day and -1.3% below its 200-day average, with the 20-day -6.6% away.

How far is REGN from its 52-week high?

15.5% below the 52-week high and 34.6% above the 52-week low, as of 2026-10-05.

Mentioned on Closelooknet

Where REGN appears in the diary — 1 piece, newest first. Every link is our own writing.

Dailies

A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000Midday 10 · 21 Aug 2026Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG…

Related in the Closelooknet universe

same Closelooknet index seat first, then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.